After the FDA’s recent authorization of emergency use of convalescent plasma, the Mayo Clinic led Expanded Access Program is ceasing new enrollment. On Sunday, the Food and Drug Administration ...
Researchers at Mayo Clinic gave an update Thursday on the experimental plasma program being used to treat patients with severe cases of COVID-19. Dr. Michael Joyner, the principal investigator, said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results